High Court Hears 'Skinny Labeling' Case That Could Make Generic Rx Harder To Get

High Court Hears 'Skinny Labeling' Case That Could Make Generic Rx Harder To Get Skinny labeling, Stat explains, is when a generic drugmaker seeks approval to market a drug for a specific use other than those for which the brand-name medicine is prescribed as a way to avoid patent infringement lawsuits. The outcome of the hearing could affect access to generics. https://kffhealthnews.org/morning-breakout/pharma-and-tech-2/